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Background. Interleukin (IL)-8 has been implicated in the development of cancer cachexia. The polymorphism of IL-8 gene, which
may aﬀect the production level of IL-8, may be associated with cancer cachexia. Methods. The serum IL-8 level in our study was
examined by radioimmunoassay. We also analyzed single nucleotide polymorphisms (SNPs) −251A/T and +781C/T of IL-8 gene,
using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results.T h es e r u ml e v e l so fI L - 8w e r e
signiﬁcantly elevated in patients with low-third gastric cancer compared with controls, and were further up-regulated in patients
with cachexia than those without (Z =− 3.134, P = .002). A signiﬁcantly increased frequency of +781 T allele was noted in
patients with cachexia (OR = 2.247, 95% CI: 1.351–3.737, P = .002). The +781 TT genotype was observed to be associated with a
signiﬁcantlyincreasedriskof cachexia (OR = 3.167, 95%CI:1.265–7.929, P = .011),andwithoddsratioof3.033(95%CI:1.065–
8.639, P = .038) for cachexia after adjusting for potential confounding factors. Meanwhile, haplotype analysis indicated a border-
line positive association between T
251T
781 haplotype and cachexia as compared with the T
251C
781 haplotype (OR = 4.92, 95% CI:
1.00–24.28; ,P = .053). Conclusions. IL-8 appears to be associated with cachexia from patients with low-third gastric cancer.
Copyright © 2009 Bo Song et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Cachexia is a complex metabolic syndrome associated with
many diseases such as cancer, acquired immunodeﬁciency
syndrome (AIDS), parasitic diseases, autoimmune disorders,
chronic heart failure, or sepsis [1, 2]. Patients with cachexia
arecharacterizedbyanorexia,earlysatiety,severeweightloss,
weakness, anemia, and edema [1, 3]. The most devastating
eﬀect of cachexia is a progressive loss of body weight,
resulting in severe depletion of both adipose tissue and
skeletal muscle [4]. But unlike the situation in starvation,
nutritional supplementation has little or no impact on
cachexia [5]. Cancer cachexia—which has a negative impact
on patient’s quality of life, therapy and survival—is the most
common reason of cancer-related deaths. It is estimated that
20% of patients with malignant diseases die from the eﬀects
of cachexia rather than tumor burden [6, 7].
The mechanism of cancer cachexia remains not well
know. In humans, there is an increasing evidence that
cytokines, including tumor necrosis factor alpha (TNF-α),
interleukin (IL)-1, IL-6, IL-8 and interferon gamma (IFN-
γ) may participate in the cause or the development of cancer
cachexia [8–13].
IL-8, a member of the CXC chemokine family, was origi-
nally identiﬁed as a potent chemoattractant for neutrophils
and lymphocytes [14, 15]. Subsequent studies conﬁrmed
that IL-8 could also induce angiogenesis, tumor growth,
invasion, and potential metastasis in cancer [16]. Recently,
the associations between increased serum IL-8 level and
cachexia have been demonstrated in several cancers [17,
18]. Some studies have reported that the two common
polymorphisms of IL-8 gene, −251A/T, and +781C/T are
associated with altered transcription levels of IL-8 [19–22],
and the polymorphisms of IL-8 gene have been implicated in
the susceptibility to a range of cancers [23–25].
It has been conﬁrmed that the IL-6 gene polymorphisms
playanimportantroleinthedevelopmentofcancercachexia
[26, 27], and the polymorphism of IL-1 β is associated2 Comparative and Functional Genomics
with the cachexia from locally advanced gastric cancer [28].
However, no study has examined the association between
genetic polymorphisms in IL-8 gene and cachexia. Working
from the assumption of substantial inﬂammatory contribu-
tion to cancer cachexia, we evaluated the eﬀects of serum
IL-8 level and the two common −251A/T and +781C/T
polymorphisms of the IL-8 gene on the susceptibility of
cachexia from patients with low-third gastric cancer.
2.MaterialsandMethods
2.1. Patients. All of the consecutive patients with low-third
gastric cancer admitted to our hospital between April 1, 2008
and October 1, 2008 were prospectively considered. All cases
were Chinese Han Population, and were veriﬁed as low-third
gastric adenocarcinoma by histopathological examination.
The exclusion criteria were the following: (1) age >75 years,
(2) anorexia nervosa, (3) pyloric obstruction (4) surgery,
radiotherapy, or chemotherapy during the previous 4 weeks,
(5) other active medical conditions (major gastrointestinal
disease, chronic heart failure, hepatic failure and renal
failure, uncontrolled diabetes, infections, and HIV).
Patients were investigated for the presence of smoking
habits, drinking water status, weight loss, food intake, and
C-reactive protein (CRP) levels. We deﬁned “current” as
persons who were current smokers, “ex-” as those who had
smoked in the past, and “never” as those who had never
smokedatanytimeintheirlives.Cancerstageswereclassiﬁed
according to the guideline of International Union Against
Cancer (UICC) TNM system [29].
All patients were divided into two groups cachectic
patients and noncachectic patients. Patients were considered
cachectic if they had met all 3 factors of the multifactor
cachexia proﬁle [30]: (1) weight loss (≥10% of their
preillness stable weight within 6 months), (2) low food
intake (≤1500kcal/d), (3) systemic inﬂammation (CRP ≥
10mg/L).
The controls were recruited from our hospital attendees
with no family history of gastric cancer and without
any malignant diseases and infectious disorders. Informed
consent was obtained from all participating subjects, and the
Medical Ethics Committee of Aﬃliated Hospital of Qindao
University approved the study.
2.2.AssessmentofHPyloriStatus. 14C-UBTtestwasrepeated
two times for enrolled patients and controls by a single team
of specialized staﬀ. None of the enrolled subjects had ever
been treated for H pylori eradication
2.3. Cytokine Detection. Peripheral venous blood samples
were collected at 6 a.m. on the ﬁrst day after admission
and all participants were in a fasting state. The levels of
the cytokines were measured by a radioimmunoassay using
Interleukin Radioimmunoassay Kit (North Biotechnology
Research Institute, Beijing, China) according to the manu-
facturer’s instructions.
2.4. DNA Extraction. Genomic DNA was extracted from
EDTA-anticoagulated peripheral blood leukocytes using
Wizard Genomic DNA Puriﬁcation kit (Promega) according
to the manufacturer’s instructions.
2.5. Determination of IL-8 Genotype. The IL-8 −251A/T and
+781C/T genotypes were determined by using a polymerase
chain reaction-restriction fragment length polymorphism
method (PCR-RFLP), and the PCR primers were designed
as described previously.
2.6. IL-8 −251A/T. Forward, CCATCATGATAGCATCTGT;
reverse, CCACAATTTGGTGAATTATTAA [31] (Shanghai
Sangon Biological Engineering Technology & Services Co.).
PCR conditions: 94
◦C 5 minutes; 35 cycles of 30 seconds at
94
◦C, 55 seconds at 57
◦C, 1 minute at 72
◦C; 72
◦C8m i n u t e s .
PCR products were digested with AseI (MBI Fermentas) for
4 hours at 37
◦C, producing fragments of 152 and 21bp for
allele A, or 173bp for allele T; the fragments were visualized
by electrophoresis on a 3% agarose gel stained with 0.1%
ethidium bromide (Figure 1).
2.7. IL-8 +781C/T. Forward, CTCTAACTCTTTATATAG-
GAATT; reverse, GATTGATTTTAT CAACAGGCA [31]
(Shanghai Sangon Biological Engineering Technology &
Services Co.). PCR conditions: 94
◦ 8 minutes; 35 cycles of
30 seconds at 94
◦C, 30 seconds at 52
◦C, 1 minute at 72
◦C;
72
◦C 10 minutes. PCR products were digested with EcoRI
(MBI Fermentas) for 4 hours at 37
◦C, producing fragments
of 184 and 19bp for allele C, or 203bp for allele T, the
fragmentswerevisualizedbyelectrophoresisona3%agarose
gel stained with 0.1% ethidium bromide (Figure 2).
2.8.StatisticalAnalysis. TheserumIL-8levelswereexpressed
as Mean ± SE and compared with Mann-Whitney U test.
Demographic and clinical data between groups were
compared by 2-sample t test and by χ2 test. Genotype
distributions for each polymorphism were ﬁrst compared
to values predicted by the Hardy-Weinberg equilibrium
through χ2 test. Genotype and allele frequencies among
groups were compared using the χ2 test and Fisher’s exact
test when appropriate, and odds ratios (OR) and 95%
conﬁdence intervals (CIs) were calculated to estimate
the relative risk conferred by a particular allele and
genotype. Haplotypes and linkage disequilibrium (LD)
were determined based on the expectation-maximization
algorithm using the SNPStats program (available at
http://bioinfo.iconcologia.net/SNPstats/ provided in the
public domain by the Biostatistics and Bioinformatics Unit,
Catalan Institute of Oncology, Barcelona, Spain). A model of
multiple logistic regression with variable entry criterion: P>
.05 and variable removal criterion: P<. 1 was also applied
for identiﬁcation of independent predictors of the cachexia.
P values were two sided and P<. 05 was considered
signiﬁcant.TheSPSSstatisticalsoftwarepackageversion12.0
was used for all of the statistical analyses.
3. Results
3.1. Characteristics of the Study Population. On the basis
of the selection criteria, 125 patients with low-third gastricComparative and Functional Genomics 3
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Figure 1: PCR-RFLP assay for analyzing the −251A/T polymor-
phism of IL-8. Lanes 1 and 6 of heterozygous AT genotype showed
three fragments of 173, 152, and 21 (not shown) bp; lane 4 and 7
homozygous of TT genotype showed only one fragment of 173bp;
lanes2,3and5ofhomozygous AAgenotypeshowedtwofragments
of 152 and 21 (not shown) bp. Lane M was loaded with 100–600bp
DNA markers.
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Figure 2: PCR-RFLP assay for analyzing the +781C/T polymor-
phism of IL-8. Lanes 4 and 5 of heterozygous CT genotype showed
three fragments of 203, 184, and 19 (not shown) bp; lane 1 and 3
of homozygous TT genotype showed only one fragment of 203bp;
lanes 2 and 6 of homozygous CC genotype showed two fragments
of 184 and 19 (not shown) bp. Lane M was loaded with 100–600 bp
DNA markers.
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Figure 3: Serum levels of cytokines in gastric cancer patients and
healthy subjects.
Table 1: Characteristics of gastric cancer patients in the analysis of
cachexia.
Cachexia Noncachexia
(n = 61) (n = 64) P
Sex (M/F) 38/23 45/19 .3433
Age (year) 55. 27±12.241 57.26 ± 11.32 .3462
Serum albumin (g/L) 28.6 ± 4.7 35.2 ± 5.1 <.0012
Actual weight (kg) 64.9 ± 8.2 65.8 ± 12.5 .6562
Carcinoma stage <.0013
I0 1 4
II 31 5
III 17 34
IV 13 11
1Mean ± SD (all such values).
22-samplet test.
3Pearson chi-square test.
Table 2: Characteristics of the cancer patients and controls.
Cancer Contr.
(n = 125) (n = 140) P
Sex (M/F) 83/42 99/41 .4503
Age (year) 56.18 ± 11.781 54.24 ± 12.03 .1852
Smoking status 0.5633
never 41 (32.8%) 54 (38.6%)
Ex- 24 (19.2%) 22 (15.7%)
current 60 (48.0%) 64 (45.7%)
Helicobacter pylori
infection 74 (59.2%) 76 (54.3%) .4203
Poor drinking
water 18 (14.4%) 13 (9.3%) .1963
1Mean ± SD (all such values).
22-sample t test.
3Pearson chi-square test.
cancer were studied (61 cachectic patients). The character-
istics of the study patients are shown in Table 1. Carcinoma
stage was noted to be signiﬁcantly diﬀerent between the two
groups (P<. 001).
The clinical characteristics of the controls and the
patients are shown in Table 2. No signiﬁcant association
was found between the frequency of smoking status, poor
drinking water status and Helicobacter pylori infection. The
t w og r o u p sw e r em a t c h e df o ra g ea n ds e x .
3.2. Serum IL-8 level in Patients and Controls. The serum
levelofIL-8ispresentedinFigure 3.TheIL-8levelinpatients
with low-third gastric cancer was signiﬁcantly higher than
that in the healthy controls (Z =− 8.186, P<. 001), and
was further up-regulated signiﬁcantly in cachectic patients
compared with non-cachectic patients (1.413 ±0.130ng/mL
versus 0.899 ± 0.076ng/mL, Z =− 3.134, P = .002). In
a logistic regression analysis adjusted for actual weight and
carcinoma stage, IL-8 was associated with odds ratio of 4.480
(95% CI: 1.527–13.142, P = .006) for cachexia.4 Comparative and Functional Genomics
Table 3:ThegenotypeandallelefrequenciesofIL-8polymorphism
in cancer patients and controls.
Polymorphism Cancer
n = 125 (%)
Contr.
n = 140 (%) χ2 P
IL-8 −251A/T 1.659 .436
AA 20 (16.0) 23 (16.4)
AT 72 (57.6) 70 (50.0)
TT 33 (26.4) 47 (35.6)
A allele 112 (44.8) 116 (41.4) 0.612 .434
T allele 138 (55.2) 164 (58.6)
IL-8 +781C/T 1.356 .508
CC 40 (32.0) 53 (37.9)
CT 58 (46.4) 63 (45.0)
TT 27 (21.6) 24 (17.1)
C allele 138 (55.2) 169 (60.4)
T allele 112 (44.8) 111 (39.6) 1.441 .230
Table 4:ThegenotypeandallelefrequenciesofIL-8polymorphism
in patients with gastric cancer.
Polymorphism Cachexia
n = 61 (%)
Noncachexia
n = 64 (%) χ2 P
IL-8 −251A/T 1.224 .542
AA 12 (19.7) 8 (12.5)
AT 34 (55.7) 38 (59.4)
TT 15 (24.6) 18 (28.1)
A allele 58 (47.5) 54 (42.2) 0.724 .395
T allele 64 (52.5) 74 (57.8)
IL-8 +781C/T 9.315 .009
CC 13 (21.3) 27 (42.2)
CT 29 (47.5) 29 (45.3)
TT 19 (31.2) 8 (12.5)
C allele 55 (45.1) 83 (64.8)
T allele 67 (54.9) 45 (35.2) 9.864 .002
3.3. The Genotype and Allele Frequencies of IL-8. The geno-
type and allele frequencies of the IL-8 gene −251A/T and
+781C/T polymorphisms for all the studied variations are
shown in Tables 3 and 4. Within each study group, the
genotype distributions were consistent with those predicted
by the Hardy-Weinberg equilibrium.
No signiﬁcant diﬀerence was found in genotype and
allele frequencies between the low-third gastric cancer
patients and the controls (Table 3). There were signiﬁcant
diﬀerences in the genotype frequencies of the IL-8 gene
+781C/T polymorphism between patients with cachexia
and without (Table 4)( P = .009), and a signiﬁcantly
increased frequency of +781T allele was noted in patients
with cachexia (OR = 2.247, 95% CI: 1.351–3.737, P = .002).
The+781TTgenotypeswereobservedtobeassociatedwitha
signiﬁcantly increased risk of cachexia (OR = 3.167, 95% CI:
1.265–7.929, P = .011), and with odds ratio of 3.033 (95%
CI: 1.065–8.639, P = .038) for cachexia after adjusting for
patients’ actual weight and carcinoma stage.
3.4. Haplotype Analysis of the IL-8 Gene. Haplotype analyses
were performed and the possible four haplotype frequencies
are shown in Table 5. Linkage disequilibrium was observed
between locus −251 and locus +781 (D  = 0.7). Haplotype
analysis revealed major T251C781 haplotype accounted
for 45.1% and 56.2% of these four haplotypes in both
the cachexia and noncachexia patients, respectively. Hap-
lotype analysis revealed that T251T
781 haplotype (deﬁned
by SNPs at positions −251 and +781) was associated with
a borderline positive risk of cachexia as compared with
the T251C781 haplotype (OR = 4.92, 95% CI: 1.00–24.28;
P = .053).
4. Discussion
Cancer-related cachexia is typiﬁed by poor prognosis and
is a signiﬁcant cause of morbidity and mortality in cancer
patients. Various studies have suggested the involvement of
certain cytokines in cachexia. On this basis, we examined
a cohort of patients with low-third gastric cancer who
had cachexia to discuss whether the elevated serum level
of IL-8 and its two common −251A/T and +781C/T
polymorphisms are related to cachexia.
In our study, serum IL-8 level was signiﬁcantly higher
in low-third gastric cancer patients than those in healthy
controls, and was further up-regulated in cachectic patients
compared with noncachectic patients. In agreement with
our results, the correlations of IL-8 concentration with the
occurrence of cachexia have been conﬁrmed in other studies
[17, 18]. Noticeably, some studies have suggested that the
primary tumor and distant metastasis may be associated
with the levels of procachectic cytokines in cancer patients.
Krzystek-Korpacka et al. [18] demonstrated that both IL-
6 and IL-8 were correlated with gastroesophageal cancer T
stage.Uedaetal.[32]reportedthatIL-6andIL-8mayplayan
important role in the hematogenous metastasis of colorectal
cancer. In view of these, we made logistic regression analysis
adjusted for actual weight and tumor stage, and found that
IL-8 was the independent predictor of cachexia in low-third
gastric cancer patients.
AlthoughtheprecisemechanismsregulatingIL-8expres-
sion remain not well known, several studies have shown
that polymorphisms of the IL-8 gene have functional
importance. Polymorphisms at position −251 and +781
of the IL-8 gene, especially the A251T781 haplotype, have
been reported to be associated with greater IL-8 production
and expression [21, 33, 34]. Tsai et al. [35]h a v eo b s e r v e d
signiﬁcant relationships between the IL-8 +781T allele and
wet age-related macular degeneration (AMD). In our study,
a signiﬁcantly increased frequency of +781T allele was noted
in patients with cachexia, and the +781TT genotype was
signiﬁcantly associated with the risk of cachexia. Thus it can
be conceivable that a higher promoter activity of +781T
allele in IL-8 gene and its TT genotype might increase theComparative and Functional Genomics 5
Table 5: IL-8 gene haplotype distribution in the patients with cachexia and with noncachexia.
Haplotype Cachexia
2n = 122 (%)
Noncachexia
2n = 128 (%)
Odds ratio (95% conﬁdence interval) P
T251C781 55 (45.1) 72 (56.2) 1.00
A251T781 58 (47.5) 43 (33.6) 1.48 (0.84 − 2.61) .17
A251C781 0 11 (8.6) 0.00 (-Inf - Inf) 1
T251T781 9 (7.4) 2 (1.6) 4.92 (1.00 - 24.28) .053
expression of IL-8, resulting in a high profuction of IL-8,
which may lead to be more susceptible to cachexia.
Previous reports have demonstrated that the −251A
allele within the promoter was signicantly associated with
higher IL-8 levels and is itself a functional variant [33, 36].
In our study, we failed to observe the relation between
IL-8 −251A/T polymorphisms and cachexia in low-third
gastric cancer patients, and in contrast, the T251T781 hap-
lotype of IL-8 gene seemed to be positively associated
with cachexia. It just can be conceivable that −251T allele
may participate in up-regulating the production of IL-
8 but can not be regarded as an independent predictor
of cachexia. In fact, it is still unclear which allele of IL-
8 −251A/T polymorphism is the functional variant that
directly aﬀects IL-8 production; the relationship has been
controversial [20, 37].
In the current study, the IL-8 +781T allele frequency
among the healthy Chinese Han population in our study
was 0.39, which was higher than that of Taiwan Chinese
populations (0.28)[35],butwascomparabletothatfoundin
previous study in healthy American populations (0.35) [32].
To eliminate possible bias, we carefully selected both our
low-third gastric cancer and control groups. First, to avoid
artifact in population admixture, we selected only Chinese
Han people. As age, smoking habits, drinking water status,
and helicobacter pylori infection are important risk factor
in gastric cancer, the control sample was all matched to the
patient group.
In conclusion, our results showed that the serum level
of IL-8 and its +781C/T polymorphism have a signiﬁcant
association with the presence of cachexia in low-third gastric
cancer patients. Future studies with larger sample sizes
will be needed to validate the genetic eﬀects of the IL-8
polymorphisms on cachexia in gastric cancer. Nevertheless,
the results of our study are limited because of the relatively
small numbers of cases and controls. Additional studies of
the exact putative biologic functions of IL-8 on cachexia are
also needed to be elucidated.
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